Autoantibodies directed against the
U2 small nuclear ribonucleoprotein (
snRNP) have been found in the serum of a patient with scleroderma-
polymyositis overlap syndrome. This specificity, called anti-(U2)-RNP, is distinct from all previously described
autoantibodies, including those that precipitate related snRNPs: anti-Sm
antibodies, which react with the entire set of U1, U2, U4, U5, and U6 snRNPs, and anti-(U1)RNP
antibodies, which recognize only U1 snRNPs. From HeLa cell extracts, anti-(U2)RNP immunoprecipitates predominantly one 32P-labeled
RNA species, identified as
U2 small nuclear RNA, and six [35S]
methionine-labeled
protein bands, A' (Mr = 32,000), B (Mr = 28,000), D (Mr = 16,000), E (Mr = 13,000), F (Mr = 12,000), and G (Mr = 11,000).
Protein blot analysis reveals that the A'
protein carries (U2)RNP
antigenic determinant(s) and therefore represents a
polypeptide unique to the
U2 snRNP; the B
protein associated with U2 snRNPs may also be unique. Like U1 and the other Sm snRNPs, U2 snRNPs occupy a nuclear, non-nucleolar location and are antigenically conserved from insects to man. An antibody specific for the
U2 snRNP will be useful in deciphering the function of this particle.